Sealonix Inc.

About Sealonix Inc.

Sealonix, Inc. is a privately held company based in Bedford, MA, focused on the development and commercialization of hemostatic sealants using proprietary biomaterials. Founded in January 2023 by serial entrepreneur Amar Sawhney, PhD, the company aims to address surgical bleeding challenges with innovative technology.

Products & Services

PramStat Patch:An experimental medical device designed to stop bleeding during surgery, particularly in abdominopelvic procedures, when other methods like suturing are ineffective. It is currently under clinical study to evaluate its safety and effectiveness compared to other commercially available hemostatic agents.

Hemostatic Sealants:Next-generation hemostatic agents developed using proprietary biomaterials, aimed at providing rapid hemostasis for various surgical procedures.

Specialties

Hemostatic Sealants Proprietary Biomaterials Surgical Bleeding Control Abdominopelvic Procedures

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series A T: - FT: Series A	A: 20000000 MR: - FA: 20 million FAN: 20000000	D: 2023-05-12 FD: 2023-05-12	6 investors

Series A Latest

2023-05-12

$20.0M

6 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

A

Amar Sawhney

Serial Entrepreneur

Recent News

Sealonix Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised